70 results
This study has been transitioned to CTIS with ID 2024-513897-23-00 check the CTIS register for the current data. The main objective of this study is to evaluate the use of molecular fluorescence imaging using cetuximab-IRDye800CW in the detection of…
Primary: To evaluate the sensitivity and specificity of dynamic contrast enhanced (DCE-MRI) to identify patients who have increased risk of disease recurrence (local, nodal, systemic) after radio-chemotherapy of cervix cancer.Secondary: To apply…
Primary Objective The primary objective of this study is to compare the 3-year overall survival of stage III NSCLC patients during follow-up surveillance with 18F FDG PET/CT versus follow-up with conventional CT surveillance. Secondary Objectives…
The objective of this study is to:1) explore the feasibility (recruitment, adherence, and absence of major technical problems) of using both medical-grade and consumer grade wearables for continuous measurement of physical activity, posture, balance…
The aim of this study is to determine whether multiparametric MRI (mpMRI) of the bladder, in combination with an outpatient biopsy for histological confirmation, is a faster, safer, cheaper and therefore more cost-effective way to detect or…
To assess the predictive value of early response measurements on PSMA-PET/CT for therapy success, defined as time to development of castration-resistant prostate cancer (CRPC), in order to personalize treatment choice.
To explore the feasibility of sentinel lymph node identification by SPIO injection followed by MRI in head-and-neck cancer patients.
This explorative study aims to investigate the added value of a 18F-PSMA PET to mpMRI in the detection of local prostate cancer lesions.
To determine whether the incidence of severe toxicity (defined as grade 3 to 5, grading according to the National Cancer Institute Common Terminology Criteria for Adverse Events, NCI CTC-AE version 5.0) associated with fluoropyrimidine treatment can…
To assess the patient level CDR and region level PPV of rhPSMA-7.3 (18F) PET for BCR of PCa using histopathology or imaging as a SoT. Secondary Objectives: 1. To assess the patient level CDR and region level PPV of rhPSMA-7.3 (18F) PET in the…
The main objectives of this study are(I) to compare the sensitivity of CT-venography and ultrasound for screening-detected, catheter-related thrombosis in cancer patients and (II) to assess intrinsic coagulation levels in cancer patients prior to…
Primary Objective: To study the feasibility of Velocity Selective Arterial Spin Labeling as a non-invasive technique for breast cancer screening by comparing image quality with DCE-MRI.Secondary Objectives: Comparing tumor characteristics and…
To evaluate the influence of anticoagulant treatment on the platelet mRNA profile in patients in whom anticoagulation is initiated.
To test if the NIPT approach is capable of detecting ctDNA in patients diagnosed with four different types of cancer.
Primary Objective: - The ability of SFR spectroscopy incorporated in EUS-FNA procedure in distinguishing benign and malignant pancreatic tissue by measuring wavelength dependent optical characteristics over a broad wavelength range (400-1000 nm).…
Develop and evaluate the potential of TEPs and ctDNA as a novel liquid biomarker for early ovarium cancer diagnostics. And to evaluate the accuracy of ctNDA on response evaluation in patients with ovarian carcinoma.
The primary objective is to investigate if ADT can increase the uptake of 68Ga-PSMA in patients with R/M SDC.
Primary objective:To identify novel variants in the DPYD gene in non-Western patients that are related to the occurrence of severe (grade *3) toxicity upon treatment with fluoropyrimidines.Secondary objective:* To determine the influence of novel…
Investigate the distribution, dosimetry and image quality of [195mPt]cisplatin in cancer patients
The primary objective is to explore endothelial function in patients before and after treatment with anthracyclines.